Literature DB >> 22051975

Comparative evaluation of anti-inflammatory properties of thymoquinone and curcumin using an asthmatic murine model.

El-Sayed M Ammar1, Nariman M Gameil, Noha M Shawky, Manar A Nader.   

Abstract

This study was designed to compare the inhibitory effects of thymoquinone (TQ) and curcumin (CMN) on the biological changes associating asthma. TQ appeared to exhibit greater inhibitory effects on the aggregation of inflammatory cells in bronchoalveolar lavage (BAL) fluid and in lung tissues. We also measured the effects of the two agents on serum IgE and the changes in the mRNA levels of inducible nitric oxide synthase (iNOS), tumor necrosis factor-α (TNF-α) and transforming growth factor-β1 (TGF-β1). Serum IgE was significantly decreased by TQ and CMN with TQ being more potent. Also, TQ showed superior inhibitory effects on iNOS and TGF-β1. Meanwhile, CMN was more potent in inhibiting mRNA expression of TNF-α. These results suggest that TQ is more potent in inhibiting the inflammatory changes associating asthma. On the other hand, CMN was a less potent inhibitor of all measured parameters, despite its superior inhibitory effect on TNF-α mRNA levels.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22051975     DOI: 10.1016/j.intimp.2011.10.013

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  21 in total

1.  Anti-inflammatory effects of thymoquinone in activated BV-2 microglial cells.

Authors:  Equar Taka; Elizabeth A Mazzio; Carl B Goodman; Natalie Redmon; Hernan Flores-Rozas; Renee Reams; Selina Darling-Reed; Karam F A Soliman
Journal:  J Neuroimmunol       Date:  2015-06-27       Impact factor: 3.478

2.  Myeloid-derived suppressor cells (MDSCs) and mechanistic target of rapamycin (mTOR) signaling pathway interact through inducible nitric oxide synthase (iNOS) and nitric oxide (NO) in asthma.

Authors:  Yanli Zhang; Boyi Xu; Bin Luan; Yan Zhang; Yanling Li; Xiaorong Xiong; Hongke Shi
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

3.  Nigella sativa Oil Reduces LPS-Induced Microglial Inflammation: An Evaluation on M 1/M 2 Balance.

Authors:  Azar Hosseini; Vafa Baradaran Rahimi; Hassan Rakhshandeh; Vahid Reza Askari
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-14       Impact factor: 2.650

Review 4.  Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.

Authors:  Bharat B Aggarwal; Subash C Gupta; Bokyung Sung
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

5.  In vivo modulation of iNOS pathway in hepatocellular carcinoma by Nigella sativa.

Authors:  Moustafa Fathy; Toshio Nikaido
Journal:  Environ Health Prev Med       Date:  2013-04-23       Impact factor: 3.674

6.  Thymoquinone reduces ischemia and reperfusion-induced intestinal injury in rats, through anti-oxidative and anti-inflammatory effects.

Authors:  Ali Parlar; Seyfullah Oktay Arslan
Journal:  Turk J Surg       Date:  2020-03-18

Review 7.  Thymoquinone: A Promising Natural Compound with Potential Benefits for COVID-19 Prevention and Cure.

Authors:  Osama A Badary; Marwa S Hamza; Rajiv Tikamdas
Journal:  Drug Des Devel Ther       Date:  2021-05-03       Impact factor: 4.162

8.  The effect of Nigella sativa oil on serum levels of inflammatory markers, liver enzymes, lipid profile, insulin and fasting blood sugar in patients with non-alcoholic fatty liver.

Authors:  Mohammad Rashidmayvan; Majid Mohammadshahi; Seyed Saeed Seyedian; Mohammad Hossein Haghighizadeh
Journal:  J Diabetes Metab Disord       Date:  2019-09-11

9.  Ameliorative Effect of Thymoquinone-Loaded PLGA Nanoparticles on Chronic Lung Injury Induced by Repetitive Intratracheal Instillation of Lipopolysaccharide in Rats.

Authors:  Sultan A M Saghir; Naif A Al-Gabri; Abdelmoniem A Ali; Al-Sayed R Al-Attar; Mosa'd Al-Sobarry; Omar Y A Al-Shargi; Amal Alotaibi; Mohammed Al-Zharani; Fahd A Nasr; Nader Al-Balagi; Mahfoudh A M Abdulghani; Sulaiman M Alnaimat; Osama Y Althunibat; Ayman M Mahmoud
Journal:  Oxid Med Cell Longev       Date:  2021-05-28       Impact factor: 6.543

10.  Thymoquinone-loaded nanostructured lipid carriers: preparation, gastroprotection, in vitro toxicity, and pharmacokinetic properties after extravascular administration.

Authors:  Siddig Ibrahim Abdelwahab; Bassem Yousef Sheikh; Manal Mohamed Elhassan Taha; Chee Wun How; Rasedee Abdullah; Umar Yagoub; Rashad El-Sunousi; Eltayeb E M Eid
Journal:  Int J Nanomedicine       Date:  2013-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.